SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE Stock Forecast & Price Target

SRNE Stock Price Forecast

The average stock forecast for Sorrento Therapeutics Inc (SRNE) in the next 12 months is 13.26 USD. This price target corresponds to an upside of 4,215.00%. The range of stock forecasts for SRNE is 13.13 - 13.65 USD. Based on the ratings of 7 analysts, the consensus recommendation for SRNE is BUY.
Target Low Average Median High
Price (USD) 13.13 13.26 13.26 13.65
Upside 4,172.70% 4,215.00% 4,215.00% 4,341.91%

Recommendation Trends

The latest consensus rating for SRNE is "BUY". This is the average recommendation of 7 analysts: 0 strong sell, 0 sell, 1 hold, 4 buy, 2 strong buy. In the previous period, 7 analysts also majorly recommmended "BUY" for SRNE.

SRNE Financial Stock Forecast

Revenue This Year
57.53M
-8.40%
from 62.80M
Revenue Next Year
210.65M
266.17%
from 57.53M
EPS This Year
-0.69
-33.90%
from -1.04
EPS Next Year
-0.33
-51.47%
from -0.69